01497nas a2200421   4500000000100000008004100001260001300042653001000055653004200065653004200107653001100149653003000160653001100190653002200201653001100223653002300234653001200257653000900269653001600278653002600294653002000320653003000340653002200370653001500392100002800407700001500435700001500450700001300465700001800478700001200496245005100508856005100559300001000610490000700620050003200627520040200659022001401061       2005                            d  c2005 Jun10aAdult10aAIDS-Related Opportunistic Infections10aAntiretroviral Therapy, Highly Active10aBrazil10aDrug Therapy, Combination10aFemale10aFollow-Up Studies10aHumans10aLeprostatic Agents10aleprosy10aMale10aMiddle Aged10aRetrospective Studies10aRisk Assessment10aSeverity of Illness Index10aTreatment Outcome10aViral Load1 aBianconcini Trindade MA1 aManini MIP1 aMasetti JH1 aLeite MA1 aTakahashi MDF1 aNaafs B00aLeprosy and HIV co-infection in five patients.  uhttps://leprosyreview.org/article/76/2/16-2166  a162-60 v76  aInfolep Library - available3 a<p>In a retrospective study, five patients are reported who suffered from a Mycobacterium leprae/HIV co-infection and were treated for their HIV infection with HAART. In four patients, this revealed their leprosy and induced a type I leprosy reaction. Two patients who were lepromin negative at diagnosis were retested after about 1 year of anti-retroviral treatment, and found to be positive.</p>  a0305-7518